Clinical Trial Update: Ranolazine Loading to Prevent PCI-induced Myocardial Injury [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether loading with ranolazine can prevent PCI-induced myocardial injury in patients with coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Ranolazine (ranolazine)

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Coronary Artery Disease | Phase 4 | Status: UNKNOWN